INSIGHTS ON QUALITY ASSURANCE

• Why Cleanroom Wipe Fabrics Matter

  Discover the key fabrics used in cleanroom wipes and how they impact performance, as well as explore substrates, manufacturing methods, and essential attributes to help you choose the right wipe.

• Getting The CAPA Framework Right The First Time

  CAPA processes, though often seen as regulatory burdens, offer significant business benefits. Implementing them requires a cultural shift and methodical approach for lasting improvement.

• Can Today's ELNs Support Tomorrow's Labs?

  The global electronic laboratory notebook (ELN) market is growing, however, ELNs must form part of a more comprehensive data strategy and ecosystem or they can impede progress.

• Compatible Platforms For Microbial Identification

  Reduce the time-to-results for microbial identification by taking advantage of the shorter run cycle and off-instrument data analysis provided by this optimized and validated workflow.

• A Blueprint For Avoiding FDA Recalls

  10/9/2024

  Avoid FDA recalls and safeguard your life sciences business. Learn how QMS and EBR/eDHR solutions can prevent costly product recalls and ensure compliance with FDA regulations.

• Enhance Peptide Innovation With A High-Quality Supply Of Building Blocks

  1/29/2025

  To leverage the benefits of peptide therapeutics, identify an experienced chemical material manufacturer that can produce unique peptide building blocks with quality, efficiency, and continuous compliance.

• ResDNASEQ Workflow Solution

  5/22/2025

  Overview of the resDNASEQ workflow solution.

• Why Biotech Leaders Can't Afford Delays In Document Review

  5/15/2025

  Document review is a hidden bottleneck in biopharma. Learn how inefficiencies in this critical process can delay drug development and what you can do to accelerate time to market.

• Could RFID-Based Unit-Level Traceability Be Key To Operational Excellence?

  9/5/2023

  Radiofrequency identification (RFID)-based unit-level tracking solutions for prefilled syringes are poised to help pharma manufacturers address key risks and costly bottlenecks related to the fill-finish process.